Company / Capital Returned to Shareholders per Share
Bio-Rad Laboratories Capital Returned to Shareholders per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$10.12
FY2025
5-year range
$1.66 / $14.19
FY2021-FY2025
Trend
+48.0%
vs FY2024
Sector context
#13 of 108
Health Care
What the data says
Bio-Rad Laboratories's capital returned to shareholders per share of $10.12 is higher than 88% of companies in the Health Care sector (FY2025). Declined from $14.19 to $10.12 over the past 2 years.
Based on SEC 10-K filings.
10.12 in FY2025 with a 5-year CAGR of +44.3%. Top quartile in the Health Care sector.
Declined from $14.19 to $10.12 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +12.3%
- 5-Year CAGR
- +44.3%
- 10-Year CAGR
- -
Sector benchmark
+107.0% above sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 48.0% year-over-year.
- Ranks #13 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2023.
- Lowest capital returned to shareholders per share in the period was in FY2018.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.12 | +48.0% |
| FY2024 | $6.84 | -51.8% |
| FY2023 | $14.19 | +98.4% |
| FY2022 | $7.15 | +331.8% |
| FY2021 | $1.66 | +2.4% |
| FY2020 | $1.62 | +73.6% |
| FY2019 | $0.93 | - |
| FY2018 | $0.00 | - |
| FY2017 | $0.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026